Neuropharmacology Poster Session |
Results Subject Group Profile At Baseline: Total number of subjects - 25; Age range - 40-77; Number hypertensive- 19; Number diabetes mellitus- 4 Study Results: Sexual Function Improvements as Measured By SFQ: Patient responses to SFQ variables at 4 weeks were compared to SFQ responses at baseline. A comparison analysis was performed for those subjects whose degree of erectile dysfunction were mild to moderate as characterized by a minimal baseline score of 2 in comparison to their 4 week score on the same SFQ variable. The results were then pooled, summarized, and evaluated to reflect the percentage of subjects with improvement in each of the SFQ variables. The following are our findings showing the two highest and two lowest SFQ variable results: 88.9% of subjects showed improvement in the ability to maintain erection during intercourse, as measured by the following SFQ variable: Over the past 4 weeks, during sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner? 0 = Did not attempt intercourse, 1 = Almost never/never, 2 = A few times (much less than half the time), 3 = Sometimes (about half the time), 4 = Most times (much more that half the time), 5 = Almost always/always 75.0% of subjects showed improvement in satisfaction with overall sex life, as measured by the following SFQ variable: Over the past 4 weeks, how satisfied have you been with your overall sex life? 1 = Very dissatisfied, 2 = Moderately dissatisfied, 3 = About equally satisfied and dissatisfied, 4 = Moderately satisfied, 5 = Very satisfied 20.0% of subjects showed improvement in number of orgasms, as measured by the following SFQ variable: Over the past 4 weeks, when you had sexual stimulation or intercourse, how often did you ejaculate? 0 = No sexual stimulation/intercourse, 1 = Almost never/never, 2 = A few times (much less than half the time), 3 = Sometimes (about half the time), 4 = Most times (much more than half the time), 5 = Almost always/always 12.5% of subjects showed improvement in the number of times attempted intercourse, as measured by the following SFQ variable: Over the past 4 weeks, how many times have you attempted sexual intercourse? 0 = No attempts, 1 = One to two attempts, 2 = Three to four attempts, 3 = Five to six attempts, 4 = Seven to ten attempts, 5 = Eleven+ attempts Subjects Dropped: Of the 25 subjects enrolled, 21 were included in the scoring of the above shown results. Four (4) of the enrolled subjects were not included for the following reasons: Loss of sex partner resulting in major change in sexual activity(1 subject). Did not complete study due to personal problems- unspecified(1 subject). Did not complete 4 week regimen in entirety (2 subjects). Side Effects: Blood Pressure Changes: no significant change in blood pressure. Mean blood pressure at baseline:135/82 (s.devs: 14.9/11.71). Mean blood pressure at 4-weeks:139/85 (s.devs:12.26/13.17). No other significant side effects as noted. The following are net % of patients reporting increase or decrease of: headaches: -4.8%, nausea: -4.8%, stomach upset: -14.3%, chest pain: 0%, dizziness: 0%, vision disturbance: 0%
| Discussion Board | Next Page | Your Poster Session | |
||||||||||
Ito, T.; Kawahara, K.; Das, A.; Strudwick, W.; (1998). The Effects of ArginMax, A Natural Dietary Supplement for Enhancement of Male Sexual Function. Presented at INABIS '98 - 5th Internet World Congress on Biomedical Sciences at McMaster University, Canada, Dec 7-16th. Available at URL http://www.mcmaster.ca/inabis98/neuropharm/ito0455/index.html | |||||||||||
© 1998 Author(s) Hold Copyright |